The global test phantoms market is anticipated to grow at a considerable CAGR of 6.7% during the forecast period. The rising number of drug discovery and development activities and R&D in medical devices is resulting in an increasing number of clinical trials in the region. North America has the largest share in drug discovery and development activities across the globe, which in turn, is resulting in growth in clinical trials in the region. As per the US FDA, in 2020, the Center for Drug Evaluation and Research (CDER) approved 53 novel drugs, either as new molecular entities (NMEs) under new drug applications (NDAs) or as new therapeutic biologics under biologics license applications (BLAs). In 2019, CDER approved 48 novel drugs, either as NMEs under NDAs or as new therapeutic biologics under BLAs. The COVID-19 outbreak is further leading to an increasing number of clinical trials in the country. In addition, the emerging focus on precision medicine is also supporting the rise in clinical trials in the country.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/test-phantoms-market
As per the Personalized Medicine Coalition, the number of personalized medicines on the market in the US has grown from 132 in 2016 to 286 in 2020. This, in turn, has resulted owing to the rising focus on the development of personalized medicines, which is supporting the rising number of clinical trials across the US. A wide range of imaging modalities is used in clinical trials which is leading to increasing demand for several different kinds of phantoms. Phantoms that are designed for positron emission tomography (PET) scans are normally used for staging and treatment monitoring. Several imaging modalities support the generation of primary, secondary and exploratory study endpoints. Imaging modalities including PET/CT, CT, and MRI offer evidence of drug effects and treatment efficacy with the delivery of response biomarkers. Phantom augments the accuracy and reliability of data obtained from medical imaging. Therefore, significant demand for medical imaging modalities in clinical trials is leveraging the demand for phantoms.
Global Test Phantoms Market Report Segment
By Product Type
- X-ray Phantoms
- Ultrasound Phantoms
- MRI Phantoms
- Nuclear Imaging
- Other
A full report of Test Phantoms Market is available at: https://www.omrglobal.com/industry-reports/test-phantoms-market
Global Test Phantoms Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- 3-Dmed
- Biodex Medical Systems, Inc.
- Mirion Technologies (Capintec) Inc.
- IBA Dosimetry GMBH
- True Phantom Solutions Inc.
- Standard Imaging Inc.
- Kyoto Kagaku Co., Ltd.
- Leeds Test Objects Ltd.
- Modus Medical Devices
- PTW-Freiburg
- Pure Imaging Phantoms
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/